NasdaqGS - Nasdaq Real Time Price USD

Agilysys, Inc. (AGYS)

86.00
+3.28
+(3.97%)
At close: 4:00:01 PM EDT
87.50
+1.50
+(1.74%)
After hours: 5:50:19 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 69.56M
Earnings 10.65M

Q1'24

Q2'24

Q3'24

Q4'24

0
20M
40M
60M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

90.00
122.00 Average
86.00 Current
178.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 5455
Avg. Estimate 0.290.341.31.64
Low Estimate 0.240.321.251.6
High Estimate 0.350.381.361.68
Year Ago EPS 0.320.31.11.3

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 5555
Avg. Estimate 71.42M73.61M272.8M318.84M
Low Estimate 70.8M71.54M272.2M315M
High Estimate 71.79M75.3M273.14M320.97M
Year Ago Sales 62.22M63.51M237.46M272.8M
Sales Growth (year/est) 14.79%15.89%14.88%16.88%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 0.280.250.30.34
EPS Actual 0.320.30.340.38
Difference 0.040.040.040.04
Surprise % 13.27%17.65%14.86%10.95%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.290.341.31.64
7 Days Ago 0.290.341.31.64
30 Days Ago 0.290.341.31.64
60 Days Ago 0.290.341.31.67
90 Days Ago 0.290.321.31.69

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --11--
Up Last 30 Days --11--
Down Last 7 Days 4--31
Down Last 30 Days 4--32

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
AGYS -10.63%14.17%17.82%26.70%
S&P 500 13.21%2.76%7.83%13.78%

Upgrades & Downgrades

Maintains Oppenheimer: Outperform to Outperform 4/9/2025
Maintains Needham: Buy to Buy 3/5/2025
Maintains Craig-Hallum: Buy to Buy 1/22/2025
Maintains Oppenheimer: Outperform to Outperform 1/22/2025
Maintains Needham: Buy to Buy 1/22/2025
Maintains Northland Capital Markets: Outperform to Outperform 1/7/2025

Related Tickers